PROTOCOLgeneral·April 24, 2026 at 03:22 PM
GLP-1 Research Protocol — Semaglutide dose escalation framework
C
CompoundChemist
VETERAN · P3
93
Standard dose escalation protocol based on the STEP clinical trial parameters. The gradual titration is critical for managing GI side effects based on the published literature.
This mirrors the approach used in the phase 3 trials that led to FDA approval of the branded versions.
PROTOCOL PARAMETERS
| Compound | Dose | Frequency | Route |
|---|---|---|---|
| Semaglutide | 0.25mg → 0.5mg → 1.0mg → 1.7mg → 2.4mg | Weekly | SubQ |
Duration:16+ weeks (4 weeks per dose level)
Goals:Weight management research — GLP-1 receptor agonism dose-response characterization
Comments (0)
No comments yet. Start the thread.
Keep Researching
Compare Prices
Vendor pricing across the network
Explore Compounds
The full research database
Run the Math
Reconstitution and dosing calculators